Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia

NCT05035589 is registered in ClinicalTrials.gov with Sciberras, Stephen M.D. as lead sponsor.

NCT NCT05035589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05035589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Lead sponsor
Sciberras, Stephen M.D.
Phase
Observational
Overall status
Completed
Start date
September 20, 2021
Completion date
November 20, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid-19 pneumonia